Alpha Teknova (TKNO) Resumen de Acciones
Alpha Teknova, Inc. produce reactivos críticos para el descubrimiento, desarrollo y comercialización de nuevas terapias, vacunas y diagnósticos moleculares en Estados Unidos y a escala internacional. Saber más
| Puntuación del snowflake | |
|---|---|
| Valoración | 2/6 |
| Crecimiento futuro | 1/6 |
| Rendimiento pasado | 0/6 |
| Salud financiera | 6/6 |
| Dividendos | 0/6 |
Recompensas
Análisis de riesgos
TKNO Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Competidores de Alpha Teknova, Inc.
Historial de precios y rendimiento
| Precios históricos de las acciones | |
|---|---|
| Precio actual de la acción | US$3.99 |
| Máximo en las últimas 52 semanas | US$7.17 |
| Mínimo de 52 semanas | US$1.91 |
| Beta | 0.47 |
| Cambio en 1 mes | 41.49% |
| Variación en 3 meses | 89.10% |
| Cambio de 1 año | -40.80% |
| Variación en 3 años | 100.50% |
| Variación en 5 años | n/a |
| Variación desde la OPV | -84.04% |
Noticias y actualizaciones recientes
Artículo de análisis • May 09
Analyst Estimates: Here's What Brokers Think Of Alpha Teknova, Inc. (NASDAQ:TKNO) After Its First-Quarter Report
Alpha Teknova, Inc. ( NASDAQ:TKNO ) defied analyst predictions to release its quarterly results, which were ahead of...
Actualización del análisis • Apr 28
TKNO: Long Term Revenue Guidance Will Support Future Upside Potential
Analysts have adjusted their price target on Alpha Teknova to $7.00 per share from $7.00, reflecting updated views on discount rates, revenue growth, profit margins, and future P/E assumptions. What's in the News Alpha Teknova issued revenue guidance for the fiscal year ending December 31, 2026, with an expected total revenue range of $42 million to $44 million (company guidance).Actualización del análisis • Apr 12
TKNO: Long Term Revenue Guidance And Higher P/E Will Support Future Upside
Analysts have adjusted their price target on Alpha Teknova to $7.00 from $7.00, reflecting updated views on discount rate, revenue growth, profit margin and future P/E assumptions. What's in the News Alpha Teknova issued revenue guidance for the fiscal year ending December 31, 2026, indicating an expected total revenue range of $42 million to $44 million.Recent updates
Artículo de análisis • May 09
Analyst Estimates: Here's What Brokers Think Of Alpha Teknova, Inc. (NASDAQ:TKNO) After Its First-Quarter Report
Alpha Teknova, Inc. ( NASDAQ:TKNO ) defied analyst predictions to release its quarterly results, which were ahead of...Actualización del análisis • Apr 28
TKNO: Long Term Revenue Guidance Will Support Future Upside Potential
Analysts have adjusted their price target on Alpha Teknova to $7.00 per share from $7.00, reflecting updated views on discount rates, revenue growth, profit margins, and future P/E assumptions. What's in the News Alpha Teknova issued revenue guidance for the fiscal year ending December 31, 2026, with an expected total revenue range of $42 million to $44 million (company guidance).Actualización del análisis • Apr 12
TKNO: Long Term Revenue Guidance And Higher P/E Will Support Future Upside
Analysts have adjusted their price target on Alpha Teknova to $7.00 from $7.00, reflecting updated views on discount rate, revenue growth, profit margin and future P/E assumptions. What's in the News Alpha Teknova issued revenue guidance for the fiscal year ending December 31, 2026, indicating an expected total revenue range of $42 million to $44 million.Actualización del análisis • Mar 26
TKNO: Long Term Revenue Guidance Will Support Future Upside Potential
Analysts have adjusted their price target on Alpha Teknova to $7.00 from $7, citing updated assumptions around discount rates, revenue growth, profit margins and future P/E that leave their fair value view essentially unchanged. What's in the News Alpha Teknova issued revenue guidance for the fiscal year ending December 31, 2026, indicating expected total revenue in a range of $42 million to $44 million.Actualización del análisis • Mar 11
TKNO: Updated Revenue Outlook Will Support Future Upside Potential
Analysts have trimmed their price target on Alpha Teknova to $7.00 from $7 as they factor in updated assumptions for the discount rate, revenue growth, profit margin and future P/E. Their view remains broadly aligned with prior estimates while they fine tune the model inputs.Actualización del análisis • Feb 25
TKNO: Steady Fair Value Anchor Will Support Future Upside Potential
Analysts have trimmed their price target on Alpha Teknova to $7.00 from $7 as they adjust assumptions around discount rates, revenue growth, profit margins, and future P/E. This reflects updated views on the company’s risk profile and earnings potential.Actualización del análisis • Feb 10
TKNO: Steady Fair Value Anchor Will Support Future Upside Potential
Narrative Update on Alpha Teknova Analysts have kept their fair value estimate for Alpha Teknova broadly steady at about $7.00. They explain that modest tweaks to assumptions, such as a slightly higher discount rate, small adjustments to revenue growth and profit margin outlooks, and a marginally lower future P/E, leave their overall price target view essentially unchanged.Actualización del análisis • Jan 27
TKNO: Earnings Guidance And Tuck In Deals Will Support Future Upside
Analysts have nudged their price target on Alpha Teknova slightly higher, citing updated assumptions around discount rates, revenue growth of about 17.6% and a future P/E near 46.1x to support a modestly refined fair value estimate of about $7.00 per share. What's in the News Alpha Teknova reiterated earnings guidance for the fiscal year ending December 31, 2025, with total revenue still expected in the range of $39 million to $42 million.Artículo de análisis • Jan 18
Alpha Teknova, Inc.'s (NASDAQ:TKNO) Share Price Is Still Matching Investor Opinion Despite 29% Slump
Unfortunately for some shareholders, the Alpha Teknova, Inc. ( NASDAQ:TKNO ) share price has dived 29% in the last...Actualización del análisis • Jan 13
TKNO: Earnings Guidance And Tuck In Deals Will Drive Future Upside
Analysts have modestly adjusted their price target on Alpha Teknova, citing an updated fair value of $7.00, a slightly higher discount rate, revised revenue growth expectations to 17.46%, a small change in the assumed profit margin, and a lower future P/E estimate of 46.25x. What's in the News Alpha Teknova reiterated earnings guidance for the fiscal year ending December 31, 2025, with expected total revenue in a range of $39 million to $42 million.Actualización del análisis • Dec 27
TKNO: Earnings Guidance And Tuck In Deals Will Support Future Upside
Narrative Update: Alpha Teknova Analysts have modestly raised their price target on Alpha Teknova by approximately $1.00 per share, reflecting slightly higher assumptions for long term revenue growth and profit margins. This is partially offset by a marginally higher discount rate and a small reduction in projected future P E multiples.Actualización del análisis • Dec 13
TKNO: Earnings Guidance And M&A Efforts Will Support Future Upside Potential
Analysts have trimmed their price target for Alpha Teknova from 8 dollars to 7 dollars, citing slightly slower expected revenue growth and a higher perceived discount rate, despite modestly better margin and valuation assumptions. What's in the News Reiterated 2025 earnings guidance, maintaining projected total revenue in the range of 39 million dollars to 42 million dollars for the year ending December 31, 2025 (company guidance).Artículo de análisis • Nov 12
Earnings Update: Here's Why Analysts Just Lifted Their Alpha Teknova, Inc. (NASDAQ:TKNO) Price Target To US$10.00
Alpha Teknova, Inc. ( NASDAQ:TKNO ) just released its quarterly report and things are looking bullish. Results overall...Artículo de análisis • Sep 25
Alpha Teknova, Inc.'s (NASDAQ:TKNO) P/S Is Still On The Mark Following 27% Share Price Bounce
Alpha Teknova, Inc. ( NASDAQ:TKNO ) shares have had a really impressive month, gaining 27% after a shaky period...Artículo de análisis • Jul 22
Alpha Teknova, Inc.'s (NASDAQ:TKNO) 26% Cheaper Price Remains In Tune With Revenues
To the annoyance of some shareholders, Alpha Teknova, Inc. ( NASDAQ:TKNO ) shares are down a considerable 26% in the...Artículo de análisis • Jun 11
Shareholders Will Probably Not Have Any Issues With Alpha Teknova, Inc.'s (NASDAQ:TKNO) CEO Compensation
Key Insights Alpha Teknova will host its Annual General Meeting on 17th of June CEO Stephen Gunstream's total...
Nuevo análisis • Mar 29
Acquisitions And Collaborations Will Expand Cell And Gene Therapy Portfolio
Expansion through collaborations and acquisitions aims to boost top-line growth, margins, and financial stability amidst anticipated market rebound.Artículo de análisis • Mar 06
Alpha Teknova, Inc. (NASDAQ:TKNO) Just Reported And Analysts Have Been Lifting Their Price Targets
Alpha Teknova, Inc. ( NASDAQ:TKNO ) shareholders are probably feeling a little disappointed, since its shares fell 9.3...Artículo de análisis • Feb 28
Alpha Teknova, Inc. (NASDAQ:TKNO) Stocks Pounded By 31% But Not Lagging Industry On Growth Or Pricing
Alpha Teknova, Inc. ( NASDAQ:TKNO ) shareholders won't be pleased to see that the share price has had a very rough...Artículo de análisis • Feb 23
Calculating The Fair Value Of Alpha Teknova, Inc. (NASDAQ:TKNO)
Key Insights The projected fair value for Alpha Teknova is US$8.71 based on 2 Stage Free Cash Flow to Equity With...Artículo de análisis • Dec 14
Revenues Tell The Story For Alpha Teknova, Inc. (NASDAQ:TKNO) As Its Stock Soars 28%
Despite an already strong run, Alpha Teknova, Inc. ( NASDAQ:TKNO ) shares have been powering on, with a gain of 28% in...Artículo de análisis • Oct 15
Revenues Tell The Story For Alpha Teknova, Inc. (NASDAQ:TKNO) As Its Stock Soars 42%
Despite an already strong run, Alpha Teknova, Inc. ( NASDAQ:TKNO ) shares have been powering on, with a gain of 42% in...Artículo de análisis • Jun 27
Alpha Teknova, Inc. (NASDAQ:TKNO) Might Not Be As Mispriced As It Looks After Plunging 30%
Unfortunately for some shareholders, the Alpha Teknova, Inc. ( NASDAQ:TKNO ) share price has dived 30% in the last...Artículo de análisis • Apr 24
Not Many Are Piling Into Alpha Teknova, Inc. (NASDAQ:TKNO) Stock Yet As It Plummets 25%
To the annoyance of some shareholders, Alpha Teknova, Inc. ( NASDAQ:TKNO ) shares are down a considerable 25% in the...Artículo de análisis • Jan 22
Health Check: How Prudently Does Alpha Teknova (NASDAQ:TKNO) Use Debt?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Artículo de análisis • Aug 14
Some Analysts Just Cut Their Alpha Teknova, Inc. (NASDAQ:TKNO) Estimates
Market forces rained on the parade of Alpha Teknova, Inc. ( NASDAQ:TKNO ) shareholders today, when the analysts...Artículo de análisis • Apr 17
Take Care Before Jumping Onto Alpha Teknova, Inc. (NASDAQ:TKNO) Even Though It's 30% Cheaper
Unfortunately for some shareholders, the Alpha Teknova, Inc. ( NASDAQ:TKNO ) share price has dived 30% in the last...Artículo de análisis • May 14
Alpha Teknova, Inc. (NASDAQ:TKNO) Just Reported, And Analysts Assigned A US$23.00 Price Target
As you might know, Alpha Teknova, Inc. ( NASDAQ:TKNO ) just kicked off its latest quarterly results with some very...Rentabilidad de los accionistas
| TKNO | US Life Sciences | Mercado US | |
|---|---|---|---|
| 7D | 6.7% | -0.2% | 2.6% |
| 1Y | -40.8% | -1.1% | 26.2% |
Rentabilidad vs. Industria: Los resultados de TKNO fueron inferiores a los de la industria US Life Sciences, que obtuvo un rendimiento del -1.1% el año pasado.
Rentabilidad vs. Mercado: TKNO obtuvo unos resultados inferiores a los del mercado US, que fueron del 26.2% el año pasado.
Volatilidad de los precios
| TKNO volatility | |
|---|---|
| TKNO Average Weekly Movement | 12.7% |
| Life Sciences Industry Average Movement | 8.3% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.1% |
| 10% least volatile stocks in US Market | 3.2% |
Precio estable de las acciones: El precio de las acciones de TKNO ha sido volátil durante los últimos 3 meses en comparación con el mercado US.
Volatilidad a lo largo del tiempo: La volatilidad semanal de TKNO(13%) se ha mantenido estable durante el último año, pero sigue siendo superior al 75% de las acciones de US.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1996 | 158 | Stephen Gunstream | www.teknova.com |
Alpha Teknova, Inc. produce reactivos críticos para el descubrimiento, desarrollo y comercialización de nuevas terapias, vacunas y diagnósticos moleculares en los Estados Unidos e internacionalmente. Los principales productos de la empresa incluyen placas de medios prevertidos para el crecimiento celular y la clonación; medios de cultivo microbiano líquidos y suplementos para la expansión celular; y reactivos de biología molecular para la manipulación, resuspensión y purificación de muestras. Ofrece productos esenciales de laboratorio que proporcionan formulaciones químicas para su uso en la investigación biológica y el descubrimiento de fármacos; y soluciones clínicas, un producto a medida utilizado en el desarrollo y la producción de terapias proteicas, terapias génicas, vacunas de ARNm y kits de diagnóstico.
Resumen de fundamentos de Alpha Teknova, Inc.
| Estadísticas fundamentales de TKNO | |
|---|---|
| Capitalización bursátil | US$204.27m |
| Beneficios(TTM) | -US$17.17m |
| Ingresos (TTM) | US$41.80m |
5.1x
Ratio precio-ventas (PS)-12.5x
Ratio precio-beneficio (PE)¿Está TKNO sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de TKNO | |
|---|---|
| Ingresos | US$41.80m |
| Coste de los ingresos | US$27.58m |
| Beneficio bruto | US$14.22m |
| Otros gastos | US$31.39m |
| Beneficios | -US$17.17m |
Últimos beneficios comunicados
Mar 31, 2026
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | -0.32 |
| Margen bruto | 34.01% |
| Margen de beneficio neto | -41.07% |
| Ratio deuda/patrimonio | 20.3% |
¿Cómo se ha desempeñado TKNO a largo plazo?
Ver rendimiento histórico y comparativaAnálisis de la empresa y estado de los datos financieros
| Datos | Última actualización (huso horario UTC) |
|---|---|
| Análisis de la empresa | 2026/05/12 23:40 |
| Precio de las acciones al final del día | 2026/05/12 00:00 |
| Beneficios | 2026/03/31 |
| Ingresos anuales | 2025/12/31 |
Fuentes de datos
Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.
| Paquete | Datos | Marco temporal | Ejemplo Fuente EE.UU. * |
|---|---|---|---|
| Finanzas de la empresa | 10 años |
| |
| Estimaciones del consenso de analistas | +3 años |
|
|
| Precios de mercado | 30 años |
| |
| Propiedad | 10 años |
| |
| Gestión | 10 años |
| |
| Principales avances | 10 años |
|
* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.
A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.
Modelo de análisis y copo de nieve
Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.
Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.
Métricas industriales y sectoriales
Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.
Fuentes analistas
Alpha Teknova, Inc. está cubierta por 7 analistas. 6 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.
| Analista | Institución |
|---|---|
| Mark Massaro | BTIG |
| Matthew Hewitt | Craig-Hallum Capital Group LLC |
| Paul Knight | KeyBanc Capital Markets Inc. |